Insulin secretion and clearance after subacute estradiol administration in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 2, 2008, Pages 484-490

  Van Pelt, Rachael E ^a,b   Schwartz, Robert S ^a   Kohrt, Wendy M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; C PEPTIDE; ESTRADIOL; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE INFUSION; HUMAN; HYPERGLYCEMIA; INSULIN CLEARANCE; INSULIN RELEASE; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 39049097269     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1657     Document Type: Article

References (40)

1. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E 2003 Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138:1-9
2. Bonds DE, Lasser N, Qi L, Brzyski R, Caan B, Heiss G, Limacher MC, Liu JH, Mason E, Oberman A, O'Sullivan MJ, Phillips LS, Prineas RJ, Tinker L 2006 The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia 49:459-468
3. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, Howard BV 2004 Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47:1175-1187
4. Godsland IF 2005 Oestrogens and insulin secretion. Diabetologia 48:2213-2220
5. El Seifi S, Green IC, Perrin D 1981 Insulin release and steroid-hormone binding in isolated islets of Langerhans in the rat: effects of ovariectomy. J Endocrinol 90:59-67
6. Takeda K, Toda K, Saibara T, Nakagawa M, Saika K, Onishi T, Sugiura T, Shizuta Y 2003 Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 176:237-246
7. Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC 1993 The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest 23:466-473
8. Crook D, Godsland IF, Hull J, Stevenson JC 1997 Hormone replacement therapy with dydrogesterone and 17 β-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow-up. Br J Obstet Gynaecol 104:298-304
9. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, Melis GB 1992 Effects of low doses of transdermal 17 β-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74:1396-1400
10. Cagnacci A, Tuveri F, Cirillo R, Setteneri AM, Melis GB, Volpe A 1997 The effect of transdermal 17-β-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration. Maturitas 28:163-167
11. Cucinelli F, Paparella P, Soranna L, Barini A, Cinque B, Mancuso S, Lanzone A 1999 Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. Eur J Endocrinol 140:215-223
12. Morin-Papunen LC, Vauhkonen I, Ruokonen A, Tapanainen JS, Raudaskoski T 2004 Effects of tibolone and cyclic hormone replacement therapy on glucose metabolism in non-diabetic obese postmenopausal women: a randomized study. Eur J Endocrinol 150:705-714
13. Gaspard UJ, Wery OJ, Scheen AJ, Jaminet C, Lefebvre PJ 1999 Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women. Climacteric 2:93-100
14. Karjalainen A, Paassilta M, Heikkinen J, Backstrom AC, Savolainen M, Kesaniemi YA 2001 Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism. Clin Endocrinol (Oxf) 54:165-173
15. Paoletti AM, Pilloni M, Orru M, Floris S, Pistis M, Guerriero S, Ajossa S, Melis GB 2002 Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel. Maturitas 42:137-147
16. Godsland IF, Gangar K, Walton C, Cust MP, Whitehead MI, Wynn V, Stevenson JC 1993 Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 42:846-853
17. Spencer CP, Godsland IF, Cooper AJ, Ross D, Whitehead M, Stevenson JC 2000 Effects of oral and transdermal 17β-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. Metabolism 49:742-747
18. Godsland IF, Manassiev NA, Felton CV, Proudler AJ, Crook D, Whitehead MI, Stevenson JC 2004 Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women. Clin Endocrinol (Oxf) 60:541-549
19. Manassiev N, Godsland IF, Crook D, Proudler AJ, Whitehead M, Stevenson JC 2002 Effect of postmenopausal oestradiol and dydrogesterone therapy on lipoproteins and insulin sensitivity, secretion, and elimination in hysterectomised women. Maturitas 42:233-242
20. Clarkson TB 2007 Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 14:373-384
21. Williams JK, Anthony MS, Honore EK, Herrington DM, Morgan TM, Register TC, Clarkson TB 1995 Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol 15:827-836
22. Van Pelt RE, Gozansky WS, Schwartz RS, Kohrt WM 2003 Intravenous estrogens increase insulin clearance and action in postmenopausal women. Am J Physiol Endocrinol Metab 285:E311-E317
23. Cefalu WT, Wagner JD, Bell-Farrow AD, Wang ZQ, Adams MR, Toffolo G, Cobelli C 1994 The effects of hormonal replacement therapy on insulin sensitivity in surgically postmenopausal cynomolgus monkeys (Macaca fascicularis). Am J Obstet Gynecol 171:440-445
24. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
25. Arciero PJ, Vucovich MD, Holloszy JO, Racette SB, Kohrt WM 1999 Comparison of short-term diet and exercise on insulin action in individuals with abnormal glucose tolerance. J Appl Physiol 86:1930-1935
26. Paoletti AM, Pilia I, Nannipieri F, Bigini C, Melis GB 2001 Comparison of pharmacokinetic profiles of a 17 β-estradiol gel 0.6 mg/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state. Maturitas 40:203-209
27. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, Dahlman-Wright K, Nilsson S, Gustafsson J-A, Efendic S, Kahn A 2006 Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49:588-597
28. Le MC,Chu K,Hu M, Ortega CS, Simpson ER, Korach KS, Tsai MJ, Mauvais-Jarvis F 2006 Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 103:9232-9237
29. Choi SB, Jang JS, Park S 2005 Estrogen and exercise may enhance β-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats. Endocrinology 146:4786-4794
30. Barros RP, Machado UF, Gustafsson JA 2006 Estrogen receptors: new players in diabetes mellitus. Trends Mol Med 12:425-431
31. Barros RP, Machado UF, Warner M, Gustafsson JA 2006 Muscle GLUT4 regulation by estrogen receptors ERβ and ERα. Proc Natl Acad Sci USA [Erratum (2006) 103:8298] 103:1605-1608
32. Muraki K, Okuya S, Tanizawa Y 2006 Estrogen receptor alpha regulates insulin sensitivity through IRS-1 tyrosine phosphorylation in mature 3T3-L1 adipocytes. Endocr J 53:841-851
33. Walker RJ, Lewis-Barned NJ, Sutherland WH, Goulding A, Edwards EA, de Jong SA, Gold E, Walker HL 2001 The effects of sequential combined oral 17β-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study. Menopause 8:27-32
34. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML 2007 Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297:1465-1477
35. Ihionkhan C, Chambliss K, Gibson L, Hahner L, Mendelsohn M, Shaul P 2002 Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circulation 91:814-820
36. Sakaguchi H, Fijimoto J, Aoki I, Tamaya T 2002 Expression of estrogen receptor α and β in myometrium of premenopausal and postmenopausal women. Steroids 68:11-19
37. Dieudonne MN, Leneveu MC, Guidicelli Y, Pecquery R 2004 Evidence for functional estrogen receptors α and β in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol 286:C655-C661
38. Porksen N, Hollingdal M, Juhl C, Butler P, Veldhuis JD, Schmitz O 2002 Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes 51(Suppl 1):S245-S254
39. Hahn RA, Eaker E, Rolka H 1997 Reliability of reported age at menopause. Am J Epidemiol [Erratum (1999) 149:201] 146:771-775
40. Sowers M, Zheng H, Tomey K, Karvonen-Gutierrez C, Jannausch M, Li X, Yosef M, Symons J 2007 Changes in body composition inwomenover six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab 92:895-901